Sanofi India Ltd - 500674 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Refund Order
Sanofi India received a CGST refund order for ₹52.08 lakh, covering pre-deposit payments made from August 2014 to June 2017. The company will appeal for the unaccepted balance claim of ₹11.63 lakh.
Apr 21 2026 18:04:00
Sanofi India Limited
Sanofi India board to meet on April 28, 2026, to consider standalone quarterly financial results for Q4 FY26. This meeting will evaluate the company's financial performance for the period ending March 2026.
Apr 20 2026 15:04:00
Sanofi India Ltd - 500674 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 31St March 2026
Sanofi India's Board will meet on April 28, 2026, to consider and approve the unaudited financial results for Q4 FY26. The trading window will be closed from April 1 to April 30, 2026.
Apr 20 2026 14:04:00
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sanofi India published newspaper advertisements today, April 3, 2026. The publications detail the company's 70th Annual General Meeting, Integrated Annual Report, remote e-voting information, and final dividend. These advertisements appeared in Business Standard (English) and Sakal (Marathi).
Apr 03 2026 16:04:00
Sanofi India Limited
Sanofi India will hold its 70th Annual General Meeting on April 29, 2026, virtually. The company has announced a final dividend of ₹48 per share for the financial year ended December 31, 2025, with the record date set for April 22, 2026, and payment by May 28, 2026.
Apr 02 2026 20:04:00
Sanofi India Limited
Sanofi India has communicated tax deduction at source (TDS) details for the final dividend of ₹48 per equity share for the financial year ended December 31, 2025. The record date for determining eligible shareholders is April 22, 2026, and shareholders are advised to update their details by April 15, 2026.
Apr 02 2026 20:04:00
Sanofi India Limited
Sanofi India has communicated tax deduction at source (TDS) details for the final dividend of ₹48 per equity share for the financial year ended December 31, 2025. The record date for determining eligible shareholders is April 22, 2026, and shareholders are advised to update their details by April 15, 2026.
Apr 02 2026 20:04:00
Sanofi India Limited
Sanofi India received Central Government approval for Mr. Deepak Arora's appointment as Managing Director for a three-year term. This approval, received on April 1, 2026, makes his appointment effective from October 27, 2025.
Apr 02 2026 19:04:00
Sanofi India Ltd - 500674 - Communication Of Tax Deduction At Source On Final Dividend For The Financial Year Ended December 31, 2025
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) on its final dividend for FY25. The record date for dividend eligibility is April 22, 2026, and all payments will now be made electronically, discontinuing physical warrants.
Apr 02 2026 19:04:00
Sanofi India Limited
Sanofi India Limited filed its Business Responsibility and Sustainability Report for FY25. The report highlights a 55% reduction in Scope 1 & 2 GHG emissions compared to the 2019 baseline and 74% of electricity procured from renewable sources.
Apr 02 2026 19:04:00
Read More